GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Gold stocks rise even as metal drops for second week
June 22, 2026 / www.canadianminingreport.com
Base outperform precious metals in slowdown from 2025 boom
June 22, 2026 / www.canadianminingreport.com
Mining stocks not looking expensive versus returns
June 15, 2026 / www.canadianminingreport.com
Gold stocks gain even as metal declines
June 15, 2026 / www.canadianminingreport.com
Gold stocks plunge on metal and equities slump
June 08, 2026 / www.canadianminingreport.com